A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With HNSCC (Master Protocol) (Pegathor Head and Neck 204)
PHASE2
The study was a phase 2 multi-cohort, non-randomized, open-label, multi-cen...
A Phase I Comparative Study of Pharmacokinetics, Safety, and Efficacy of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma
PHASE1
The primary objective of this clinical study is to compare the pharmacokine...
Status
Completed
Location
Regional State Budgetary Healthcare Institution "Altai Regional Oncological Dispensary"
Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Either Osimertinib in Participants With Unresectable, Locally Advanced, or Metastatic Non-Small Cell Lung Cancer, or With Cetuximab in Participants With Metastatic Colorectal Cancer
PHASE1
The main purpose of the study is to evaluate the safety of GDC-1971 in comb...